Pharmacy News

HHS announces standard definition for opioid withdrawal in infants

HHS, along with leading clinicians, researchers, and policy experts, has established a standard clinical definition for opioid withdrawal in infants. Additionally, they have created a set of foundational principles that highlight bioethical uses for the definition that focus on identifying clinical and supportive care needs for mothers and their infants.

Two powerful drugs now adding to overdoses in U.S.

A new report published by CDC reveals that medical examiners are seeing a growing number of overdose deaths linked to two opioids: parafluorofentanyl and metonitazene. These drugs are frequently taken or blended with fentanyl and are said to be more powerful than fentanyl.

Review finds too few innovative drugs in antibiotic development pipeline

A review in Antimicrobial Agents and Chemotherapy found that the antibiotic development pipeline has comparatively few clinically differentiated products in late-stage clinical development, particularly against critical, multidrug-resistant pathogens.

Most patients see pharmacists as crucial part of their health care team

Nearly 80% of patients said they see pharmacists as an integral part of their health care team, according to a new survey from Columbia University Mailman School of Public Health.

FDA warns of dental problems associated with certain buprenorphine medications

FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.